ACRYSTA Trademark

Trademark Overview


On Friday, May 24, 2024, a trademark application was filed for ACRYSTA with the United States Patent and Trademark Office. The USPTO has given the ACRYSTA trademark a serial number of 98568282. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, November 4, 2024. This trademark is owned by ESTEVE PHARMACEUTICALS, S.A.. The ACRYSTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain
acrysta

General Information


Serial Number98568282
Word MarkACRYSTA
Filing DateFriday, May 24, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, November 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameESTEVE PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBarcelona 08038
ES

Trademark Events


Event DateEvent Description
Friday, May 24, 2024NEW APPLICATION ENTERED
Tuesday, August 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 30, 2024ASSIGNED TO EXAMINER
Monday, November 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 4, 2024NON-FINAL ACTION E-MAILED
Monday, November 4, 2024NON-FINAL ACTION WRITTEN